This position paper updates the classification of epilepsy syndromes starting in childhood, simplifying terminology and focusing on seizure semiology. The syndromes are divided into self-limited focal epilepsies, generalized epilepsies, and developmental and/or epileptic encephalopathies, with revised names and diagnostic criteria to enhance clarity and aid management.

Several authors disclosed financial ties to pharmaceutical companies involved in epilepsy treatment, including consulting fees, speaker honoraria, research funding, and advisory board positions. These relationships could potentially influence the interpretation and presentation of information in the paper.

This paper provides a valuable update to the classification of childhood epilepsy syndromes, improving clarity and facilitating diagnosis. However, the lack of original research and reliance on expert consensus limit its scientific impact.